Clinical trial
Tacrolimus for Mild Thrombocytopenia in Sjogren's Syndrome
NCT05678335 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tacrolimus for Mild Thrombocytopenia in Sjogren's Syndrome
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- February 28, 2023
- Completion date
- March 31, 2024
- Enrollment
- 54 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sjogren syndrome with other organ involvement